Medical Castration Using the Investigational Oral GnRH Antagonist TAK-385 (Relugolix): Phase 1 Study in Healthy Males-Reference-Cited by-同舟云学术

Medical Castration Using the Investigational Oral GnRH Antagonist TAK-385 (Relugolix): Phase 1 Study in Healthy Males

Published:2015-12-01 Issue:12 Volume:100 Page:4579-4587
ISSN:0021-972X
Container-title:The Journal of Clinical Endocrinology & Metabolism
language:en
Short-container-title:

Author:

MacLean David B.¹,Shi Hongliang¹,Faessel Hélène M.¹,Saad Fred²

Affiliation:

1. Millennium Pharmaceuticals, Inc, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited (D.B.M., H.S., H.F.), Cambridge, Massachusetts 02139

2. University of Montreal Hospital Center (F.S.), Montreal, Québec, Canada H2X 0A9

Publisher

The Endocrine Society

Subject

Biochemistry, medical,Clinical Biochemistry,Endocrinology,Biochemistry,Endocrinology, Diabetes and Metabolism

Link

http://academic.oup.com/jcem/article-pdf/100/12/4579/10422783/jcem4579.pdf

Reference23 articles.

1. New considerations for ADT in advanced prostate cancer and the emerging role of GnRH antagonists;Shore;Prostate Cancer Prostatic Dis,2013

2. An update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancer;Rick;Onco Targets Ther,2013

3. Flare associated with LHRH-agonist therapy;Thompson;Rev Urol,2001

4. Additional analysis of the secondary end point of biochemical recurrence rate in a phase 3 trial (CS21) comparing degarelix 80 mg versus leuprolide in prostate cancer patients segmented by baseline characteristics;Tombal;Eur Urol,2010

5. The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer;Klotz;BJU Int,2008

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and Safety of Radiotherapy Plus Relugolix in Men With Localized or Advanced Prostate Cancer;JAMA Oncology;2024-05-01

2. Evaluating relugolix for the treatment of prostate cancer in real-world settings of care: the OPTYX study protocol;Future Oncology;2024-03-15

3. Visible-light-induced C(sp³)–H bromination of 4-methylthiophene derivatives with HBr/H₂O₂;Organic & Biomolecular Chemistry;2024

4. Data Mining and Analysis for Safety Signals of Degarelix Based on FAERS;Pharmacy Information;2024

5. Impact of Relugolix Versus Leuprolide on the Quality of Life of Men with Advanced Prostate Cancer: Results from the Phase 3 HERO Study;European Urology;2023-12